{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:23:33Z","timestamp":1793996613053,"version":"4.8.0"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113804","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T05:26:59Z","timestamp":1630042019000},"page":"113804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Synthetically-tailored and nature-derived dual COX-2\/5-LOX inhibitors: Structural aspects and SAR"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1710-870X","authenticated-orcid":false,"given":"Minakshi A.","family":"Meshram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2255-9879","authenticated-orcid":false,"given":"Utkarsha O.","family":"Bhise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0833-8738","authenticated-orcid":false,"given":"Priyanka N.","family":"Makhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2840-861X","authenticated-orcid":false,"given":"Venkata Rao","family":"Kaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113804_bib1","series-title":"A\u00a0Text-Book of Pathology","author":"Mohan","year":"2010"},{"key":"10.1016\/j.ejmech.2021.113804_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11515-011-1123-9","article-title":"An overview of inflammation: mechanism and consequences","volume":"6","author":"Ahmed","year":"2011","journal-title":"Front. Biol."},{"key":"10.1016\/j.ejmech.2021.113804_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12199-018-0740-1","article-title":"Inflammation and cancer","volume":"23","author":"Murata","year":"2018","journal-title":"Environ. Health Prev. Med."},{"key":"10.1016\/j.ejmech.2021.113804_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1164\/ajrccm.154.5.8912772","article-title":"Alveolar tissue inflammation in asthma","volume":"154","author":"Kraft","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2021.113804_bib5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113804_bib6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113804_bib7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113804_bib8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2021.113804_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.autrev.2010.12.006","article-title":"Inflammation as \u201ccommon soil\u201d of the multifactorial diseases","volume":"10","author":"Scrivo","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejmech.2021.113804_bib10","series-title":"Foye's Princ. Med. Chem.","first-page":"955","article-title":"Nonsteroidal anti-inflammatory drugs","author":"Borne","year":"2013"},{"key":"10.1016\/j.ejmech.2021.113804_bib11","first-page":"4631","article-title":"Advances in antitumor effects of NSAIDs","volume":"10","author":"Zhang","year":"2018","journal-title":"Canc. Manag. Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib12","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113804_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/258209","article-title":"Current perspectives in NSAID-induced Gastropathy","author":"Sinha","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2021.113804_bib15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.tcm.2016.04.011","article-title":"FDA labeling of NSAIDs: review of nonsteroidal anti-inflammatory drugs in cardiovascular disease","volume":"26","author":"Pirlamarla","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ejmech.2021.113804_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/14740338.2014.907792","article-title":"Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies","volume":"13","author":"Salvo","year":"2014","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2021.113804_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1590\/2175-8239-jbn-2018-0107","article-title":"Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs","volume":"41","author":"Lucas","year":"2019","journal-title":"Brazilian J. Nephrol."},{"key":"10.1016\/j.ejmech.2021.113804_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/qjmed\/hcg138","article-title":"Hepatocellular damage from non-steroidal anti-inflammatory drugs","volume":"96","author":"O\u2019connor","year":"2003","journal-title":"QJM An Int. J. Med."},{"key":"10.1016\/j.ejmech.2021.113804_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/VHRM.S54159","article-title":"Risk of stroke associated with nonsteroidal anti-inflammatory drugs","volume":"10","author":"Bavry","year":"2014","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejmech.2021.113804_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0165-6147(99)01385-1","article-title":"Cyclooxygenase 2 inhibitors: discovery, selectivity and the future","volume":"20","author":"Marnett","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113804_bib21","first-page":"96","article-title":"Gastrointestinal safety of novel nonsteroidal anti-inflammatory drugs: selective COX-2 inhibitors and beyond","volume":"78","author":"Coruzzi","year":"2007","journal-title":"Acta Biomed."},{"key":"10.1016\/j.ejmech.2021.113804_bib22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1503\/cmaj.1041606","article-title":"Rofecoxib (Vioxx) voluntarily withdrawn from market","volume":"171","author":"Sibbald","year":"2004","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.ejmech.2021.113804_bib23","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib24","doi-asserted-by":"crossref","first-page":"103890","DOI":"10.1016\/j.bioorg.2020.103890","article-title":"Synthesis, in\u00a0vivo anti-inflammatory, COX-1\/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives","volume":"102","author":"Qandeel","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib25","first-page":"81","article-title":"A\u00a0new avenue in anti-inflammatory therapy: dual inhibitors of cyclooxygenase and 5-lipoxygenase","volume":"1","author":"G\u00f6k\u015fen","year":"2010","journal-title":"Hacettepe Univ Eczac. Fak Derg."},{"key":"10.1016\/j.ejmech.2021.113804_bib26","first-page":"249","article-title":"Medicinal chemistry approaches for multitarget drugs","author":"Morphy","year":"2003","journal-title":"Burger\u2019s Med. Chem. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113804_bib27","series-title":"The pharmacological basis of therapeutics","author":"Laurence L Brunton","year":"2014"},{"key":"10.1016\/j.ejmech.2021.113804_bib28","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/cr2002799","article-title":"Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways","volume":"111","author":"Rouzer","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113804_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2021.113804_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-2952(02)01422-3","article-title":"Advances in the pathophysiology of constitutive and inducible cyclooxygenases\u00a0: two enzymes in the spotlight","volume":"65","author":"Parente","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113804_bib31","series-title":"New Compr. Biochem.","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0167-7306(02)36015-0","article-title":"Chapter 13 the eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase pathways","author":"Smith","year":"2002"},{"key":"10.1016\/j.ejmech.2021.113804_bib32","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/cr2002992","article-title":"Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis","volume":"111","author":"Smith","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113804_bib33","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2174\/0929867024606713","article-title":"New trends in dual 5-LOX\/COX inhibition","volume":"9","author":"Leval","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/ard.62.6.501","article-title":"Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs","volume":"62","author":"Martel-Pelletier","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2021.113804_bib35","doi-asserted-by":"crossref","first-page":"23679","DOI":"10.1074\/jbc.274.34.23679","article-title":"Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate","volume":"274","author":"Brash","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib36","first-page":"161","article-title":"Mechanisms of disease leukotrienes","volume":"31","author":"Collins","year":"1993","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113804_bib37","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2044.2000.01271.x","article-title":"Cyclo-oxygenase isoenzymes: physiological and pharmacological role","volume":"55","author":"Kam","year":"2000","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ejmech.2021.113804_bib39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nsb1196-927","article-title":"Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2","volume":"3","author":"Luong","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ejmech.2021.113804_bib40","doi-asserted-by":"crossref","first-page":"45763","DOI":"10.1074\/jbc.M305481200","article-title":"A\u00a0novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser530 and Tyr385","volume":"278","author":"Rowlinson","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113804_bib42","first-page":"655","article-title":"Selective COX-2 inhibitors: a review of their structure-activity relationships","volume":"10","author":"Zarghi","year":"2011","journal-title":"J.\u00a0Pharm. Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1107\/S2053230X16014230","article-title":"Crystal structure of rofecoxib bound to human cyclooxygenase-2","volume":"72","author":"Orlando","year":"2016","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Commun."},{"key":"10.1016\/j.ejmech.2021.113804_bib44","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1021\/acs.biochem.5b00930","article-title":"Identification of the substrate access portal of 5-lipoxygenase","volume":"54","author":"Mitra","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113804_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41589-020-0544-7","article-title":"Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products","volume":"16","author":"Gilbert","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113804_bib46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2007.06.002","article-title":"5-Lipoxygenase: regulation of expression and enzyme activity","volume":"32","author":"R\u00e5dmark","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2021.113804_bib47","series-title":"Insights into 5-Lipoxygenase Active Site and Catalysis","author":"Mitra","year":"2015"},{"key":"10.1016\/j.ejmech.2021.113804_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/jm050870x","article-title":"Structural insights into human 5-lipoxygenase inhibition: combined ligand-based and target-based approach","volume":"49","author":"Charlier","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0223-5234(03)00115-6","article-title":"Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs","volume":"38","author":"Charlier","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/1389557043403747","article-title":"Recent development in the field of dual COX\/5-LOX inhibitors","volume":"4","author":"Julemont","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejps.2018.06.003","article-title":"Safer anti-inflammatory therapy through dual COX-2\/5-LOX inhibitors: a structure-based approach","volume":"121","author":"Jaismy Jacob","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2021.113804_bib52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejmech.2015.04.044","article-title":"Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: dual inhibition of 5-LOX and COX-2 enzymes","volume":"97","author":"Singh","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib53","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2174\/1568026616666160506130731","article-title":"Thiazole: a review on chemistry, synthesis and therapeutic importance of its derivatives","volume":"16","author":"Chhabria","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib54","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/14756360802519558","article-title":"Synthesis of 4-benzyl-1,3-thiazole derivatives as potential anti-inflammatory agents: an analogue-based drug design approach","volume":"24","author":"Sharma","year":"2009","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib55","first-page":"316","article-title":"Anti-oxidant and anti-inflammatory activities of synthetic 2,4-bis(aryl\/heteroaryl)-5-acylthiazole derivatives","volume":"4","author":"Rakesh","year":"2014","journal-title":"Asian J. Biochem. Pharmaceut. Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib56","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1021\/jm00025a010","article-title":"Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs","volume":"38","author":"Bell","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib57","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2019.03.042","article-title":"Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors","volume":"171","author":"Taher","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib58","doi-asserted-by":"crossref","first-page":"103882","DOI":"10.1016\/j.bioorg.2020.103882","article-title":"Identification and development of thiazole leads as COX-2\/5-LOX inhibitors through in\u00a0vitro and in\u00a0vivo biological evaluation for anti-inflammatory activity","volume":"100","author":"Jacob P","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00044-020-02655-9","article-title":"Novel approach of multi-targeted thiazoles and thiazolidenes toward anti-inflammatory and anticancer therapy\u2014dual inhibition of COX-2 and 5-LOX enzymes","volume":"30","author":"Jacob P","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2016.09.021","article-title":"Synthesis, characterization and molecular docking studies of substituted 4-coumarinylpyrano[2,3-c]pyrazole derivatives as potent antibacterial and anti-inflammatory agents","volume":"125","author":"Chougala","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib61","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00044-013-0623-3","article-title":"Synthesis and antibacterial activity of 4,4\u2032-(aryl or alkyl methylene)-bis(1H-pyrazol-5-ol) derivatives","volume":"23","author":"Bhavanarushi","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib62","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejmech.2014.03.033","article-title":"Synthesis, structure-activity relationships, and in\u00a0vitro antibacterial and antifungal activity evaluations of novel pyrazole carboxylic and dicarboxylic acid derivatives","volume":"78","author":"Mert","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib63","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1007\/s00044-014-0909-0","article-title":"Synthesis, biological evaluation, and molecular docking studies of pyrazolyl-acylhydrazone derivatives as novel anticancer agents","volume":"23","author":"Xing","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib64","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.bmcl.2014.02.045","article-title":"Synthesis and structure\u2013activity analysis of diphenylpyrazolodiazene inhibitors of the HIV-1 Nef virulence factor","volume":"24","author":"Iyer","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113804_bib65","doi-asserted-by":"crossref","first-page":"12961","DOI":"10.3390\/molecules171112961","article-title":"4-(1H-pyrazol-1-yl)benzenesulfonamide derivatives: identifying new active antileishmanial structures for use against a neglected disease","volume":"17","author":"Marra","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113804_bib66","doi-asserted-by":"crossref","first-page":"2000027","DOI":"10.1002\/ardp.202000027","article-title":"Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2\/5-LOX inhibitors","volume":"353","author":"Shaaban","year":"2020","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2021.113804_bib67","doi-asserted-by":"crossref","first-page":"112066","DOI":"10.1016\/j.ejmech.2020.112066","article-title":"Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2\/5-LOX inhibitors","volume":"189","author":"Gedawy","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib68","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bioorg.2017.08.014","article-title":"Pyrazole-hydrazone derivatives as anti-inflammatory agents: design, synthesis, biological evaluation, COX-1,2\/5-LOX inhibition and docking study","volume":"74","author":"Abdelgawad","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bioorg.2018.03.011","article-title":"Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2\/5-LOX enzymes: histopathological and docking studies","volume":"78","author":"Abdelgawad","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib70","doi-asserted-by":"crossref","first-page":"e5386","DOI":"10.7717\/peerj.5386","article-title":"Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators","volume":"6","author":"Corigliano","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.ejmech.2021.113804_bib71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ejmech.2016.08.013","article-title":"Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: synthesis, biological activities in\u00a0vitro and docking study","volume":"123","author":"Lamie","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib72","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmech.2015.07.047","article-title":"Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype","volume":"102","author":"Santos","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14756366.2015.1024673","article-title":"Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents","volume":"31","author":"Cihan-\u00dcst\u00fcnda\u011f","year":"2015","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib74","first-page":"84","article-title":"Synthesis and evaluation of some novel N,N-Dialkylaminoalkoxy-2-oxo-indole-3-ylidene benzohydrazides as anticonvulsant agents","volume":"12","author":"Madhira","year":"2017","journal-title":"IOSR J. Pharm. Biol. Sci."},{"key":"10.1016\/j.ejmech.2021.113804_bib75","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.bmcl.2006.01.066","article-title":"Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2, Bioorg","volume":"16","author":"Jiang","year":"2006","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113804_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2016.05.025","article-title":"Indoles - a promising scaffold for drug development","volume":"91","author":"Sravanthi","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2021.113804_bib77","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1021\/acs.jmedchem.5b00952","article-title":"Triblock conjugates: identification of a highly potent antiinflammatory agent","volume":"58","author":"Singh","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib78","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1016\/j.bmc.2008.01.047","article-title":"Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors","volume":"16","author":"Reddy","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2019.07.004","article-title":"Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX","volume":"180","author":"Huang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib80","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/carcin\/bgm265","article-title":"Licofelone, a dual COX\/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade","volume":"29","author":"Tavolari","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejmech.2021.113804_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2015.11.013","article-title":"Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy","volume":"108","author":"Cai","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib82","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1016\/j.ejmech.2011.08.015","article-title":"Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents","volume":"46","author":"Bano","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib83","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.arabjc.2015.05.015","article-title":"Synthesis, characterization and cytotoxic investigations of novel bis(indole) analogues besides antimicrobial study","volume":"12","author":"Choppara","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib84","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1139\/y89-073","article-title":"L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor","volume":"67","author":"Gillard","year":"1989","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113804_bib85","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1016\/j.bmcl.2014.09.085","article-title":"Synthesis and identification of \u03b1-cyano bis(indolyl)chalcones as novel anticancer agents","volume":"24","author":"Kumar","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113804_bib86","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.bmc.2014.04.027","article-title":"Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors","volume":"22","author":"Baytas","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib87","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.bmc.2014.02.028","article-title":"Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib88","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bmcl.2017.02.052","article-title":"Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents","volume":"27","author":"Bhale","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113804_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2018.07.029","article-title":"1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: their anti-proliferative & anti-inflammatory activity","volume":"81","author":"Naaz","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib90","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.ejmech.2011.02.036","article-title":"Synthesis, spectral, crystal structure and in\u00a0vitro antimicrobial evaluation of imidazole\/benzotriazole substituted piperidin-4-one derivatives","volume":"46","author":"Ramachandran","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib91","first-page":"306","article-title":"Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy, Cancer Chemother","volume":"58","author":"Liu","year":"2006","journal-title":"Pharmacol"},{"key":"10.1016\/j.ejmech.2021.113804_bib92","first-page":"41","article-title":"Solvent-free microwave-assisted synthesis of oxadiazoles containing imidazole moiety","volume":"119","author":"Frank","year":"2007","journal-title":"J.\u00a0Chem. Sci."},{"key":"10.1016\/j.ejmech.2021.113804_bib93","first-page":"127","article-title":"Synthesis and biological evaluation of some 2,4,5-triphenyl imidazole derivatives","volume":"1","author":"Yasodha","year":"2009","journal-title":"J.\u00a0Pharmaceut. Sci. Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib94","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/0975-7406.111822","article-title":"Synthesis and biological evaluation of di- and tri-substituted imidazoles as safer anti-inflammatory-antifungal agents","volume":"5","author":"Husain","year":"2013","journal-title":"J.\u00a0Pharm. BioAllied Sci."},{"key":"10.1016\/j.ejmech.2021.113804_bib95","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bmc.2006.10.025","article-title":"Antinociceptive and antiinflammatory activities and QSAR studies on 2-substituted-4,5-diphenyl-1H-imidazoles","volume":"15","author":"Puratchikody","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib96","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/jps.2600640909","article-title":"Flumizole, a new nonsteroidal anti-inflammatory agent","volume":"64","author":"Wiseman","year":"1975","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113804_bib97","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0960-894X(99)00105-5","article-title":"Terphenyl cyclooxygenase-2 (COX-2) inhibitors: optimization of the central ring and o-biphenyl analogs","volume":"9","author":"Pinto","year":"1999","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113804_bib98","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/ml400500e","article-title":"2-(2-Arylphenyl)benzoxazole as a novel anti-inflammatory scaffold: synthesis and biological evaluation","volume":"5","author":"Seth","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113804_bib99","first-page":"104","article-title":"Benzothiazole - versatile heterocyclic nucleus in medicinal chemistry: a review","volume":"5","author":"Raju","year":"2015","journal-title":"Int. J. Pharmaceut. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib100","doi-asserted-by":"crossref","first-page":"1700311","DOI":"10.1002\/ardp.201700311","article-title":"Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2\/LOX inhibitors","volume":"351","author":"Lamie","year":"2018","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2021.113804_bib101","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113804_bib102","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/cbdd.12336","article-title":"Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents","volume":"84","author":"Mohammed","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.113804_bib103","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.taap.2018.04.019","article-title":"Effects of phenidone (DuCLOX-2\/5 inhibitor) against N-methyl-N-nitrosourea induced mammary gland carcinoma in albino rats","volume":"351","author":"Gautam","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113804_bib104","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1039\/b808895k","article-title":"Stereoselective cyclopropanation of serine- and threonine-derived oxazines to access new morpholine-based scaffolds","volume":"6","author":"Sladojevich","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejmech.2019.03.008","article-title":"Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2\/5-LOX inhibitors and antitumor agents","volume":"169","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib106","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bmcl.2011.10.106","article-title":"Bioorganic & Medicinal Chemistry Letters Synthesis and cytotoxic evaluation of thiourea and N-bis-benzothiazole derivatives\u00a0: a novel class of cytotoxic agents","volume":"22","author":"Kumbhare","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113804_bib107","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1007\/s00044-011-9908-6","article-title":"A\u00a0facile green synthesis and in\u00a0vitro antimicrobial activity 4H-pyrimido[2,1-b][1,3]benzothiazole derivatives using aluminum trichloride under solvent free conditions","volume":"21","author":"Sahu","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib108","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bmcl.2011.10.064","article-title":"Bioorganic & medicinal chemistry letters as anti-tubercular agents","volume":"22","author":"Telvekar","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113804_bib109","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/80300342","article-title":"Synthesis of new cyano-substituted bis-benzothiazolyl arylfurans and arylthiophenes","volume":"8","author":"Racan\u00e8","year":"2003","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113804_bib110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejmech.2012.02.002","article-title":"Synthesis and preliminary antibacterial evaluation of Linezolid-like 1,2,4-oxadiazole derivatives","volume":"50","author":"Palumbo Piccionello","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib111","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ejmech.2006.12.022","article-title":"New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity","volume":"42","author":"Lankau","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib112","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1016\/j.ejmech.2010.09.016","article-title":"Convenient synthesis and biological profile of 5-amino-substituted 1,2,4-oxadiazole derivatives","volume":"45","author":"Ispikoudi","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib113","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molstruc.2018.01.060","article-title":"Focused library design and synthesis of 2-mercapto benzothiazole linked 1,2,4-oxadiazoles as COX-2\/5-LOX inhibitors","volume":"1159","author":"Yatam","year":"2018","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2021.113804_bib114","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2010.01.023","article-title":"Review homeostasis and inflammation in the intestine","volume":"140","author":"Garrett","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113804_bib115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0031-1280430","article-title":"Redox and non-redox mechanism of in\u00a0vitro cyclooxygenase inhibition by natural quinones","volume":"78","author":"Landa","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2021.113804_bib116","first-page":"105","article-title":"Inhibition of in\u00a0vitro leukotriene B50 biosynthesis in human neutrophil granulocytes and docking studies of natural quinones","volume":"8","author":"Landaa","year":"2013","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejmech.2021.113804_bib117","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bcp.2013.04.015","article-title":"Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin","volume":"86","author":"Schaible","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113804_bib118","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1055\/s-0042-102460","article-title":"Miconidin acetate and primin as potent 5-lipoxygenase inhibitors from Brazilian Eugenia hiemalis (myrtaceae)","volume":"3","author":"Zatelli","year":"2016","journal-title":"Planta Med. Lett."},{"key":"10.1016\/j.ejmech.2021.113804_bib119","doi-asserted-by":"crossref","first-page":"112620","DOI":"10.1016\/j.ejmech.2020.112620","article-title":"Synthesis, inhibitory activity and in silico docking of dual COX\/5-LOX inhibitors with quinone and resorcinol core","volume":"204","author":"Sisa","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4172\/2161-0444.1000361","article-title":"5-Aminosalicyclic acid (5-ASA): a unique anti-inflammatory salicylate","volume":"6","author":"Abdu Allah","year":"2016","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib121","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1001\/jama.1982.03330170043025","article-title":"Diflunisal: a new oral analgesic with an unusually long duration of action","volume":"248","author":"Forbes","year":"1982","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2021.113804_bib122","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4172\/2329-6798.1000194","article-title":"Pharmacological potential of benzamide analogues and their uses in medicinal chemistry","volume":"4","author":"Asif","year":"2016","journal-title":"Mod. Chem. Appl."},{"key":"10.1016\/j.ejmech.2021.113804_bib123","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0223-5234(01)01251-X","article-title":"Synthesis of substituted benzamides as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 but do not cause gastric damage","volume":"36","author":"Caliendo","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib124","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0022-2275(20)32193-3","article-title":"Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid","volume":"39","author":"Batta","year":"1998","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1521-4184(19999)332:9<321::AID-ARDP321>3.0.CO;2-A","article-title":"Antiulcer effect of the N- and 0-\u03b2-D-glucopyranosides of 5-aminosalicylic acid","volume":"332","author":"Sztaricskai","year":"1999","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2021.113804_bib126","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bioorg.2018.02.023","article-title":"Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: synthesis, biological evaluation and docking study","volume":"78","author":"El-Nagar","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib127","first-page":"1","article-title":"Characterization and antiinflammatory properties of fractionated pyroligneous acid from palm kernel shell","author":"Rabiu","year":"2020","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.ejmech.2021.113804_bib128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.fitote.2018.10.016","article-title":"Evaluation of anti-inflammatory and immunomodulatory effects of Premna integrifolia extracts and assay-guided isolation of a COX-2\/5-LOX dual inhibitor","volume":"131","author":"Azad","year":"2018","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2021.113804_bib129","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1055\/s-2006-947227","article-title":"Boswellic acids in chronic inflammatory diseases","volume":"72","author":"Ammon","year":"2006","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2021.113804_bib130","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bmc.2009.01.022","article-title":"Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins","volume":"17","author":"Gauthier","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib131","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2174\/1570193X1103140915111703","article-title":"Anti-inflammatory effects of triterpenoids; naturally occurring and synthetic agents","volume":"11","author":"Jeong","year":"2014","journal-title":"Mini-Reviews Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib132","first-page":"303","article-title":"Anti-Inflammatory and Anti-Cancer Activity of Boswellic Acids from Frankincense (Boswellia serrata Roxb. et Colebr, B. carterii Birdw.)","volume":"2","author":"Efferth","year":"2011","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2021.113804_bib133","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.apjtb.2017.05.001","article-title":"Phytochemistry and potential therapeutic actions of Boswellic acids: a mini-review","volume":"7","author":"Iram","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.ejmech.2021.113804_bib134","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1211\/jpp.61.10.0003","article-title":"Boswellia resin: from religious ceremonies to medical uses; a review of in\u00a0vitro, in\u00a0vivo and clinical trials","volume":"61","author":"Moussaieff","year":"2009","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113804_bib135","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0140-6736(90)93080-9","article-title":"Glycyrrhetinic acid and potentiation of hydrocortisone activity in skin","volume":"335","author":"Mackenzie","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113804_bib136","first-page":"635","article-title":"18\u0391-Glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes","volume":"39","author":"Shetty","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2021.113804_bib137","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1021\/acs.jnatprod.9b00538","article-title":"Structure\u2013activity relationships of pentacyclic triterpenoids as inhibitors of cyclooxygenase and lipoxygenase enzymes","volume":"82","author":"Vo","year":"2019","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113804_bib138","doi-asserted-by":"crossref","first-page":"16204","DOI":"10.1038\/s41598-020-73203-z","article-title":"Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways","volume":"10","author":"das Chagas Pereira de Andrade","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113804_bib139","doi-asserted-by":"crossref","first-page":"112985","DOI":"10.1016\/j.jep.2020.112985","article-title":"Anti-inflammatory and anti-nociceptive activities of Alpinia oxyphylla Miquel extracts in animal models","volume":"260","author":"Yu","year":"2020","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113804_bib140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43094-020-00028-y","article-title":"In\u00a0vitro antioxidant, anti-inflammatory, and anticancer activities of methanolic extract and its metabolites of whole plant Cardiospermum canescens Wall","volume":"6","author":"Ketha","year":"2020","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2021.113804_bib141","doi-asserted-by":"crossref","first-page":"108379","DOI":"10.1016\/j.jnutbio.2020.108379","article-title":"Conjugated linoleic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in mice through dual inhibition of COX-2\/5-LOX and TLR4\/NF-\u03baB signaling","volume":"81","author":"Tang","year":"2020","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.ejmech.2021.113804_bib142","doi-asserted-by":"crossref","first-page":"113631","DOI":"10.1016\/j.jep.2020.113631","article-title":"Dendropanax dentiger (Harms) Merr. root and its major constituents exert therapeutic effect on adjuvant-induced arthritis in rats","volume":"267","author":"Yang","year":"2021","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113804_bib143","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.foodchem.2019.01.128","article-title":"Parallel in\u00a0vitro and in silico investigations into anti-inflammatory effects of non-prenylated stilbenoids","volume":"285","author":"Lel\u00e1kov\u00e1","year":"2019","journal-title":"Food Chem."},{"key":"10.1016\/j.ejmech.2021.113804_bib144","doi-asserted-by":"crossref","first-page":"108882","DOI":"10.1016\/j.biopha.2019.108882","article-title":"Albizia anthelmintica: HPLC-MS\/MS profiling and in\u00a0vivo anti-inflammatory, pain killing and antipyretic activities of its leaf extract","volume":"115","author":"Sobeh","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2021.113804_bib145","doi-asserted-by":"crossref","first-page":"15965","DOI":"10.1038\/s41598-020-72840-8","article-title":"Dual COX and 5-LOX inhibition by clerodane diterpenes from seeds of Polyalthia longifolia (Sonn.) Thwaites","volume":"10","author":"Nguyen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113804_bib146","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.foodres.2017.12.066","article-title":"Specialized oxygenated heterocyclics from Villorita cyprinoides with cyclooxygenase-2 and 5-lipoxygenase inhibitory properties","volume":"106","author":"Joy","year":"2018","journal-title":"Food Res. Int."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342100653X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342100653X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:35:11Z","timestamp":1759329311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342100653X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":145,"alternative-id":["S022352342100653X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113804","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetically-tailored and nature-derived dual COX-2\/5-LOX inhibitors: Structural aspects and SAR","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113804"}}